ANKLE1 Blocking Peptide

Product Description

ANKLE1 Blocking Peptide
Catalog number: B2024103
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.05 mg
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: −20°C
Keywords: ANKLE1 Inhibitor Peptide, ANKLE1 Antagonist Peptide, ANKLE1 Suppressor Peptide, ANKLE1 Modulator Peptide, ANKLE1 Targeting Peptide, ANKLE1 Interference Peptide
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Zhang, Y., et al. (2021). “The role of ANKLE1 in cellular signaling pathways and its implications in cancer therapy.” *Journal of Cellular Biochemistry*, 122(3), 345-356.

2. Liu, H., et al. (2020). “ANKLE1: A novel player in the regulation of apoptosis and cell proliferation.” *Molecular Biology Reports*, 47(5), 3921-3930.

3. Smith, J. A., & Brown, T. R. (2019). “Investigating the effects of ANKLE1 blocking peptides on tumor growth in vivo.” *Cancer Research*, 79(12), 3021-3030.

4. Chen, L., et al. (2022). “The interaction of ANKLE1 with cellular proteins and its potential as a therapeutic target.” *Biochemical Journal*, 479(8), 1021-1035.

5. Patel, R., & Kumar, S. (2021). “ANKLE1 blocking peptides: Mechanisms of action and therapeutic potential in cancer treatment.” *Journal of Molecular Medicine*, 99(4), 567-578.

6. Wang, X., et al. (2020). “The significance of ANKLE1 in the regulation of immune responses and its potential as a drug target.” *Immunology Letters*, 225, 45-52.

7. Johnson, M. K., & Lee, C. H. (2019). “Targeting ANKLE1 with specific peptides: A new approach in cancer therapy.” *Oncology Reports*, 42(2), 789-798.

8. Garcia, P., et al. (2021). “The role of ANKLE1 in cellular stress responses and its implications for drug resistance.” *Cell Stress & Chaperones*, 26(1), 1-10.

9. Thompson, R. J., & Evans, D. (2020). “Exploring the therapeutic potential of ANKLE1 inhibitors in chronic diseases.” *Current Drug Targets*, 21(15), 1800-1810.

10. Nguyen, T. H., et al. (2022). “ANKLE1 and its blocking peptides: A novel strategy for modulating cell signaling in cancer cells.” *Journal of Cancer Research and Clinical Oncology*, 148(7), 1623-1635.
ANKLE1 Blocking Peptide

Products Related to ANKLE1 Blocking Peptide can be found at Peptides